#USA #New York #Inc. #Securities Fraud #Rosen Law Firm #LifeMD

Investors of LifeMD Have an Opportunity to Lead a Lawsuit

In recent developments, investors of LifeMD, Inc. (NASDAQ: LFMD) are presented with a significant opportunity to join a class action lawsuit filed by The Rosen Law Firm. This firm specializes in protecting investor rights and has issued a reminder for those who purchased LifeMD securities between May 7, 2025, and August 5, 2025.

Important Deadline for Investors

The firm has set a crucial deadline of October 27, 2025, which marks the last day for potential lead plaintiffs to act in the ongoing securities fraud lawsuit. If you purchased LifeMD securities during the specified period, it’s essential to understand that you may be entitled to compensation. Importantly, this can be done without requiring any fees upfront, thanks to a contingency fee arrangement that Rosen Law provides.

How to Join the Class Action

Interested investors can easily join the class action through a simple process. They can visit the provided link on the Rosen Law Firm's website or contact attorney Phillip Kim directly via phone or email for further details. It is essential for investors to act promptly to secure their position within the class action and consider the opportunity to serve as lead plaintiff, representing other investors in the case.

Why Choose The Rosen Law Firm?

Rosen Law Firm has established a proven track record in securities class actions. Investors are encouraged to choose a firm with experience and a successful history in advocacy, especially since many firms that issue notices may not have comparable resources or expertise. The Rosen Law Firm has been recognized for achieving the largest securities class action settlement against a Chinese company and has consistently ranked among the top firms in terms of securities class action settlements.

What the Lawsuit Entails

The lawsuit claims that during the Class Period, the defendants made materially false or misleading statements regarding LifeMD's market position, as well as reckless projections about the company's growth that failed to account for significant customer acquisition costs. These misrepresentations have significantly affected investors, leading to potential damages once the truth about the company's operational challenges came to light.

Next Steps for Investors

To participate in this class action, investors must be aware that no class has yet been certified. Therefore, unless they choose to hire a counsel, they are not represented in the litigation. Investors prefer to retain their choice of legal counsel or remain passive participants at this stage. It is key to note that any potential recovery will not depend on serving as lead plaintiff.

Stay Updated on the Case

For further updates regarding the case and important developments, investors are encouraged to follow The Rosen Law Firm's social media pages on LinkedIn and Twitter. Keeping informed will be crucial for stakeholders looking to navigate this complex legal scenario effectively.

In conclusion, this current situation poses a significant opportunity for investors seeking justice and potential compensation for their losses tied to LifeMD, Inc. By joining the class action, they can be proactive in advocacy efforts and take part in the recovery process resulting from alleged securities fraud. Those interested should act quickly to ensure they meet the October deadline and navigate this process with informed guidance from experienced legal counsel.